Archives
-
Stress Fiber Anisotropy Regulates Force-Dependent Gene Expre
2026-06-03
Wei et al. (2020) reveal that the orientation and organization of actin stress fibers determine how living cells transduce different applied force modes into chromatin stretching and gene upregulation. Their work integrates advanced 3D magnetic twisting cytometry and modeling to clarify the mechanical basis for force-mode–dependent gene expression, with broad implications for cytoskeletal dynamics research.
-
Bestatin Dissects Jasmonate Signaling Pathways in Arabidopsi
2026-06-03
The reference study reveals how bestatin, an aminopeptidase inhibitor, serves as a chemical genetics tool to unravel jasmonate signaling mechanisms in Arabidopsis. By generating and analyzing bestatin-resistant mutants, the authors identify novel genetic loci involved in jasmonate-mediated plant defense and development.
-
TCAIM Regulates Mitochondrial Metabolism via OGDH Degradatio
2026-06-02
Wang et al. reveal that the mitochondrial DNAJC co-chaperone TCAIM specifically binds to and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels, thereby modulating mitochondrial metabolism. This discovery elucidates a previously unrecognized post-translational regulatory mechanism for the TCA cycle, with implications for metabolic pathway research and disease modeling.
-
Quercetin as a PI3K Inhibitor: Innovations in Cancer and Fer
2026-06-02
Explore how Quercetin, a potent PI3K inhibitor, advances cancer research and ferroptosis-focused therapies. This article delivers unique mechanistic insights and practical assay guidance based on the latest scientific evidence.
-
Inhaled mRNA and siRNA Overcome Collagen Barriers in Lung Ca
2026-06-01
This study introduces an inhalable lipid nanoparticle system for co-delivery of mRNA encoding anti-DDR1 scFv and siRNA targeting PD-L1, disrupting tumor collagen alignment and alleviating immunosuppression in lung cancer. The findings reveal enhanced T-cell infiltration, tumor regression, and improved survival, suggesting a dual-modality RNA strategy to remodel the tumor microenvironment.
-
Advancing In Vitro Drug Response Evaluation in Cancer Resear
2026-06-01
Schwartz (2022) introduces a refined framework for distinguishing between proliferative arrest and cell death in in vitro cancer drug assays, revealing that these metrics capture distinct aspects of drug efficacy. This work has important implications for the design, interpretation, and translational relevance of preclinical screening platforms.
-
Jasplakinolide: Elite Actin Polymerization Inducer for Preci
2026-05-31
Jasplakinolide, a potent actin polymerization inducer, empowers researchers to probe cytoskeletal dynamics with unmatched fidelity. Its membrane permeability, nanomolar F-actin affinity, and dual induction/stabilization capacity make it indispensable for live-cell imaging, cytotoxicity assays, and antifungal research.
-
CUDC-907: Technical Use Guide for Dual PI3K and HDAC Inhibit
2026-05-30
CUDC-907 enables simultaneous inhibition of PI3K and HDAC pathways in controlled in vitro cancer research, providing a tool to study cell signaling, cell cycle, and apoptosis. It is not suitable for diagnostic or therapeutic applications and should only be used within rigorously managed laboratory protocols.
-
Chemical Genetics Dissects Jasmonate Signaling in Arabidopsi
2026-05-29
The reference study establishes bestatin as a chemical genetics tool to dissect jasmonate (JA) signaling in Arabidopsis, revealing novel genetic loci involved in plant defense responses. These findings provide a framework for leveraging small molecules to unravel complex hormone signaling pathways in plant biology.
-
Proteolytic Neuroligin 1 Fragments Sustain Social Memory
2026-05-29
Liu et al. reveal that social interaction triggers proteolytic cleavage of neuroligin 1 in the ventral hippocampus, generating an intracellular fragment essential for maintaining social memory. This mechanism links extracellular signaling to synaptic plasticity, advancing our understanding of memory persistence and potential molecular targets for neuropsychiatric disorders.
-
Novel AR Antagonists Targeting Dimer Interface to Overcome R
2026-05-28
This study reports the discovery and optimization of benzo[b]oxepine derivatives as androgen receptor (AR) antagonists that target a non-canonical dimer interface pocket, overcoming key resistance mutations in prostate cancer. The work highlights Y5, a compound with dual mechanisms—disrupting AR dimerization and promoting AR degradation—demonstrating efficacy in drug-resistant models and offering a new therapeutic strategy beyond classical ligand-binding pocket inhibition.
-
SAG: Smoothened Receptor Agonist for Hedgehog Pathway Precis
2026-05-28
Smoothened Agonist (SAG) empowers researchers to precisely activate the Hedgehog signaling pathway in developmental, neuroregenerative, and disease models. This article delivers practical workflows, advanced applications, and troubleshooting insights, translating frontier research into actionable protocols for reliable and reproducible outcomes.
-
Jasplakinolide: Transforming Actin Cytoskeleton Research Too
2026-05-27
Jasplakinolide, a marine-derived actin polymerization inducer, is reshaping cytoskeletal research by delivering superior control over actin assembly and stability. This article integrates mechanistic insights, competitive benchmarking, and practical guidance, equipping translational researchers to bridge fundamental cell biology with clinical and antifungal innovation. Drawing on evidence from recent chemical genetics studies, we explore the strategic deployment of Jasplakinolide in translational workflows, highlight its role versus alternative agents, and provide actionable parameters for reproducible experimentation.
-
(-)-Blebbistatin: Precision Myosin II Inhibition in Arrhythm
2026-05-27
Explore how (-)-Blebbistatin, a selective non-muscle myosin II inhibitor, enables advanced research into cardiac conduction and cellular biomechanics. This article offers a unique, evidence-driven perspective connecting cytoskeletal modulation to arrhythmia modeling and translational assay strategy.
-
Actin–Myosin II Network Regulates Duck Enteritis Virus Proli
2026-05-26
This study uncovers how the duck enteritis virus (DEV) protein VP26 interacts with the host actin–myosin II cytoskeletal network, particularly MYH9, to regulate viral replication. By combining proteomic screening and functional assays, the research demonstrates that targeted disruption of actin polymerization—using agents such as Latrunculin A—significantly reduces DEV proliferation, revealing new antiviral intervention points.